STOCK TITAN

[8-K] DBV Technologies S.A. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

DBV Technologies S.A. filed an 8-K reporting a set of corporate filings and agreements dated September 5, 2025. The filing references a S-3 registration statement No. 333-271166 and a Sales Agreement between DBV and Citizens JMP Securities, LLC executed on September 5, 2025. Legal opinion and consent from Gide Loyrette Nouel A.A.R.P.I. are included (Exhibit 5.1), and a company press release dated September 5, 2025 is furnished. The document includes an interactive Inline XBRL cover page and is signed by Virginie Boucinha, Chief Financial Officer.

The filing is procedural and confirms registration and an at-the-market style sales agreement that could enable securities offers under the S-3 shelf; however, the 8-K does not disclose offering size, pricing, or timing.

DBV Technologies S.A. ha presentato un 8-K che riporta una serie di filing societari e accordi datati 5 settembre 2025. La filing fa riferimento a una presentazione di registrazione S-3 n. 333-271166 e a un Accordo di Vendita tra DBV e Citizens JMP Securities, LLC eseguito il 5 settembre 2025. Include un'opinione legale e consenso da Gide Loyrette Nouel A.A.R.P.I. (Exhibit 5.1), e una comunicazione stampa dell'azienda datata 5 settembre 2025 fornita. Il documento comprende una pagina di copertina Inline XBRL interattiva ed è firmato da Virginie Boucinha, Chief Financial Officer.

Il filing è procedurale e conferma la registrazione e un accordo di vendita in stile at-the-market che potrebbe permettere offerte di titoli ai sensi del S-3 shelf; tuttavia, l'8-K non indica dimensioni dell'offerta, prezzo o tempistica.

DBV Technologies S.A. presentó un 8-K informando un conjunto de presentaciones corporativas y acuerdos fechados en 5 de septiembre de 2025. La presentación hace referencia a una declaración de registro S-3 No. 333-271166 y a un Acuerdo de Venta entre DBV y Citizens JMP Securities, LLC ejecutado el 5 de septiembre de 2025. Se incluye opinión legal y consentimiento de Gide Loyrette Nouel A.A.R.P.I. (Exhibit 5.1), y se adjunta un comunicado de prensa de la empresa con fecha 5 de septiembre de 2025. El documento incluye una página de portada interactiva Inline XBRL y está firmado por Virginie Boucinha, Directora Financiera (CFO).

El filing es procedimental y confirma la registración y un acuerdo de venta en estilo at-the-market que podría habilitar ofertas de valores bajo el S-3 shelf; sin embargo, el 8-K no divulga tamaño de la oferta, precios ni calendario.

DBV Technologies S.A.2025년 9월 5일로 날짜가 표기된 일련의 회사 제출 및 계약을 보고하는 8-K를 제출했습니다. 이 제출서는 S-3 등록 신청서 No. 333-271166Sales Agreement를 DBV와 Citizens JMP Securities, LLC 간에 2025년 9월 5일에 체결했다고 언급합니다. 법적 의견 및 동의서가 Gide Loyrette Nouel A.A.R.P.I.에서 포함되어 있으며(Exhibit 5.1), 회사의 보도자료가 2025년 9월 5일에 제공됩니다. 문서에는 대화형 Inline XBRL 표지 페이지가 포함되어 있으며 Virginie Boucinha 최고재무책임자(CFO)가 서명했습니다.

이 제출서는 절차적이며 S-3 선반에 따라 증권 공모가 가능할 수 있는 등록 및 시장에서의 매매형 계약을 확인하지만, 8-K는 공모 규모, 가격 또는 시기를 공개하지 않습니다.

DBV Technologies S.A. a déposé un 8-K décrivant un ensemble de dépôts et d'accords d'entreprise datés du 5 septembre 2025. Le dépôt fait référence à une déclaration d'enregistrement S-3 No. 333-271166 et à un Accord de Vente entre DBV et Citizens JMP Securities, LLC signé le 5 septembre 2025. Une opinion juridique et le consentement de Gide Loyrette Nouel A.A.R.P.I. sont inclus (Exhibit 5.1), et un communiqué de presse de l'entreprise daté du 5 septembre 2025 est fourni. Le document comprend une page de couverture Inline XBRL interactive et est signée par Virginie Boucinha, directrice financière (CFO).

Le dépôt est procédural et confirme l'enregistrement et un accord de vente de type « at-the-market » qui pourrait permettre des offres de titres sous le S-3 shelf ; toutefois, le 8-K ne divulgue pas la taille de l'offre, le prix ou le calendrier.

DBV Technologies S.A. hat eine 8-K eingereicht, die eine Reihe von Unternehmensunterlagen und Vereinbarungen mit dem Datum 5. September 2025 enthält. Die Einreichung verweist auf eine S-3 Registrierungsanmeldung Nr. 333-271166 und auf eine Sales Agreement zwischen DBV und Citizens JMP Securities, LLC, die am 5. September 2025 abgeschlossen wurde. Eine Rechtsgutachten und Zustimmung von Gide Loyrette Nouel A.A.R.P.I. sind enthalten (Exhibit 5.1), und eine unternehmenspressemitteilung vom 5. September 2025 wird beigelegt. Das Dokument enthält eine interaktive Inline XBRL-Cover-Seite und ist von Virginie Boucinha, Chief Financial Officer, unterschrieben.

Die Einreichung ist prozedural und bestätigt die Registrierung sowie eine über den Markt (at-the-market) gestützte Verkaufsvereinbarung, die Wertpapierangebote gemäß dem S-3 Shelf ermöglichen könnte; jedoch macht das 8-K keine Angabe zur Emissionsgröße, Preisgestaltung oder Timing.

DBV Technologies S.A. قدمت ملفاً من النوع 8-K يعرض مجموعة من التسجيلات والاتفاقيات المؤسسية بتاريخ 5 سبتمبر 2025. يشير الملف إلى بيان تسجيل S-3 رقم 333-271166 واتفاقية بيع بين DBV وCitizens JMP Securities, LLC تم تنفيذها في 5 سبتمبر 2025. يتضمن الملف رأياً قانونياً وموافقة من Gide Loyrette Nouel A.A.R.P.I. (Exhibit 5.1)، كما يتم توفير بيان صحفي للشركة مؤرخ في 5 سبتمبر 2025. يحتوي المستند على صفحة غلاف Inline XBRL تفاعلية، وهو موقع من Virginie Boucinha، المدير المالي التنفيذي (CFO).

الملف إجرائي ويؤكد التسجيل واتفاقية بيع على نمط السوق المفتوح التي قد تسمح بعروض الأوراق المالية بموجب S-3 shelf؛ مع ذلك، لا يكشف الـ 8-K عن حجمOffering، أو التسعير، أو توقيت ذلك.

DBV Technologies S.A. 已提交一份包含一系列公司备案与协议的8-K,日期为2025年9月5日。该备案提到一份S-3注册声明No. 333-271166与一份由Citizens JMP Securities, LLC与DBV于2025年9月5日签署的销售协议。包含来自Gide Loyrette Nouel A.A.R.P.I.的法律意见及同意(Exhibit 5.1),并提供一份日期为2025年9月5日的公司新闻稿。该文件还包括一个互动的 Inline XBRL 封面页面,并由Virginie Boucinha,首席财务官(CFO)签署。

该备案具有程序性,确认注册以及一种基于市场销售的销售协议,可能使在S-3 存量框架下进行证券发行成为可能;但8-K并未披露发行规模、定价或时间表。

Positive
  • S-3 registration in place (No. 333-271166), enabling registered offerings
  • Sales Agreement with Citizens JMP Securities executed on September 5, 2025, providing a mechanism to raise capital
  • Legal opinion and consent from Gide Loyrette Nouel included, supporting offer legality
Negative
  • None.

Insights

TL;DR: The S-3 and sales agreement create a ready mechanism to raise capital, but no size or timetable is disclosed.

The S-3 registration combined with a sales agreement with a broker-dealer typically permits an issuer to sell shares into the market over time rather than in a single block. This structure offers flexibility for incremental capital raising without a separate registered offering each time.

The key dependencies are undisclosed: the aggregate amount of shares available under the shelf, planned issuance pace, and any board authorizations. Watch for an offering notice or supplemental prospectus that states amounts and placement timing within the next weeks to months.

TL;DR: Inclusion of a counsel opinion and Inline XBRL is standard, reducing disclosure friction but not signaling transaction specifics.

An opinion and consent from external counsel and an Inline XBRL cover page are routine elements that accompany registered offerings and help meet legal and SEC technical filing requirements. Their presence supports the mechanics of any future sales under the shelf.

Risks to monitor include any disclaimers in the counsel opinion and any subsequent amendments to the S-3 that change terms; expect further filings if shares are actually placed under the sales agreement within 30–90 days.

DBV Technologies S.A. ha presentato un 8-K che riporta una serie di filing societari e accordi datati 5 settembre 2025. La filing fa riferimento a una presentazione di registrazione S-3 n. 333-271166 e a un Accordo di Vendita tra DBV e Citizens JMP Securities, LLC eseguito il 5 settembre 2025. Include un'opinione legale e consenso da Gide Loyrette Nouel A.A.R.P.I. (Exhibit 5.1), e una comunicazione stampa dell'azienda datata 5 settembre 2025 fornita. Il documento comprende una pagina di copertina Inline XBRL interattiva ed è firmato da Virginie Boucinha, Chief Financial Officer.

Il filing è procedurale e conferma la registrazione e un accordo di vendita in stile at-the-market che potrebbe permettere offerte di titoli ai sensi del S-3 shelf; tuttavia, l'8-K non indica dimensioni dell'offerta, prezzo o tempistica.

DBV Technologies S.A. presentó un 8-K informando un conjunto de presentaciones corporativas y acuerdos fechados en 5 de septiembre de 2025. La presentación hace referencia a una declaración de registro S-3 No. 333-271166 y a un Acuerdo de Venta entre DBV y Citizens JMP Securities, LLC ejecutado el 5 de septiembre de 2025. Se incluye opinión legal y consentimiento de Gide Loyrette Nouel A.A.R.P.I. (Exhibit 5.1), y se adjunta un comunicado de prensa de la empresa con fecha 5 de septiembre de 2025. El documento incluye una página de portada interactiva Inline XBRL y está firmado por Virginie Boucinha, Directora Financiera (CFO).

El filing es procedimental y confirma la registración y un acuerdo de venta en estilo at-the-market que podría habilitar ofertas de valores bajo el S-3 shelf; sin embargo, el 8-K no divulga tamaño de la oferta, precios ni calendario.

DBV Technologies S.A.2025년 9월 5일로 날짜가 표기된 일련의 회사 제출 및 계약을 보고하는 8-K를 제출했습니다. 이 제출서는 S-3 등록 신청서 No. 333-271166Sales Agreement를 DBV와 Citizens JMP Securities, LLC 간에 2025년 9월 5일에 체결했다고 언급합니다. 법적 의견 및 동의서가 Gide Loyrette Nouel A.A.R.P.I.에서 포함되어 있으며(Exhibit 5.1), 회사의 보도자료가 2025년 9월 5일에 제공됩니다. 문서에는 대화형 Inline XBRL 표지 페이지가 포함되어 있으며 Virginie Boucinha 최고재무책임자(CFO)가 서명했습니다.

이 제출서는 절차적이며 S-3 선반에 따라 증권 공모가 가능할 수 있는 등록 및 시장에서의 매매형 계약을 확인하지만, 8-K는 공모 규모, 가격 또는 시기를 공개하지 않습니다.

DBV Technologies S.A. a déposé un 8-K décrivant un ensemble de dépôts et d'accords d'entreprise datés du 5 septembre 2025. Le dépôt fait référence à une déclaration d'enregistrement S-3 No. 333-271166 et à un Accord de Vente entre DBV et Citizens JMP Securities, LLC signé le 5 septembre 2025. Une opinion juridique et le consentement de Gide Loyrette Nouel A.A.R.P.I. sont inclus (Exhibit 5.1), et un communiqué de presse de l'entreprise daté du 5 septembre 2025 est fourni. Le document comprend une page de couverture Inline XBRL interactive et est signée par Virginie Boucinha, directrice financière (CFO).

Le dépôt est procédural et confirme l'enregistrement et un accord de vente de type « at-the-market » qui pourrait permettre des offres de titres sous le S-3 shelf ; toutefois, le 8-K ne divulgue pas la taille de l'offre, le prix ou le calendrier.

DBV Technologies S.A. hat eine 8-K eingereicht, die eine Reihe von Unternehmensunterlagen und Vereinbarungen mit dem Datum 5. September 2025 enthält. Die Einreichung verweist auf eine S-3 Registrierungsanmeldung Nr. 333-271166 und auf eine Sales Agreement zwischen DBV und Citizens JMP Securities, LLC, die am 5. September 2025 abgeschlossen wurde. Eine Rechtsgutachten und Zustimmung von Gide Loyrette Nouel A.A.R.P.I. sind enthalten (Exhibit 5.1), und eine unternehmenspressemitteilung vom 5. September 2025 wird beigelegt. Das Dokument enthält eine interaktive Inline XBRL-Cover-Seite und ist von Virginie Boucinha, Chief Financial Officer, unterschrieben.

Die Einreichung ist prozedural und bestätigt die Registrierung sowie eine über den Markt (at-the-market) gestützte Verkaufsvereinbarung, die Wertpapierangebote gemäß dem S-3 Shelf ermöglichen könnte; jedoch macht das 8-K keine Angabe zur Emissionsgröße, Preisgestaltung oder Timing.

00-0000000 true 0001613780 false 0001613780 2025-09-05 2025-09-05 0001613780 us-gaap:CommonStockMember 2025-09-05 2025-09-05 0001613780 dei:AdrMember 2025-09-05 2025-09-05
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

September 5, 2025

Date of Report (Date of earliest event reported)

 

 

DBV Technologies S.A.

(Exact name of registrant as specified in its charter)

 

 

 

France   001-36697   Not applicable

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

107 avenue de la République

92320 Châtillon France

  Not Applicable
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: +33 1 55 42 78 78

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Ordinary shares, nominal value €0.10 per share   n/a   The Nasdaq Stock Market LLC *
American Depositary Shares, each representing five ordinary shares, nominal value €0.10 per share   DBVT   The Nasdaq Stock Market LLC

 

*

Not for trading, but only in connection with the registration of the American Depositary Shares on The Nasdaq Stock Market LLC.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 8.01

Other Events.

On September 5, 2025, DBV Technologies S.A. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with Citizens JMP Securities, LLC (“Citizens”) with respect to an equity offering program (the “Offering”) pursuant to which the Company may offer and sell American Depositary Shares (“ADS”), each ADS representing five ordinary shares, from time to time, through Citizens as its sales agent. Pursuant to the Sales Agreement and a prospectus supplement the Company has filed relating to the Offering, the Company may offer and sell ADSs having an aggregate offering price of up to $150.0 million (subject to French regulatory limits) from time to time through Citizens.

The issuance and sale, if any, of the ADSs by the Company under the Sales Agreement will be made pursuant to the Company’s previously filed and effective registration statement on Form S-3 (Registration Statement No. 333-271166).

Sales of the Company’s ADSs, if any, in the Offering may be made in sales deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), from time to time. Citizens is not required to sell any specific number or dollar amount of securities, but will act as sales agent and use commercially reasonable efforts to arrange on the Company’s behalf for the sale of all ADSs requested to be sold by the Company, consistent with Citizens’ normal sales and trading practices. There is no arrangement for funds to be received in any escrow, trust or similar arrangement. Sales may also be conducted, with the Company’s consent, in negotiated transactions.

The Company will pay Citizens a commission equal to three percent (3.0%) of the gross sales price per ADS sold through Citizens under the Sales Agreement. In addition, the Company will reimburse Citizens for certain expenses incurred in connection with the Sales Agreement, and the Company has agreed to provide indemnification and contribution to Citizens with respect to certain liabilities, including liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

The Company is not obligated to make any sales of ADSs pursuant to the Sales Agreement. The Sales Agreement will terminate upon the earlier of (i) the sale of all ADSs subject to the Sales Agreement and (ii) the termination of the Sales Agreement as permitted therein. Each of the Company and Citizens may terminate the Sales Agreement at any time upon ten trading days’ prior notice.

The foregoing description of the Sales Agreement is not complete and is qualified in its entirety by reference to the full text of the Sales Agreement, a copy of which is filed herewith as Exhibit 1.1 and is incorporated herein by reference. A copy of the legal opinion of Gide Loyrette Nouel A.A.R.P.I., the Company’s French counsel, relating to the legality of the issuance of the ordinary shares in the Offering is attached as Exhibit 5.1 hereto.

This Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein.

The Company issued a press release announcing the establishment of the Offering on September 5, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act.


Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit    Description
1.1    Sales Agreement, dated as of September 5, 2025, by and between DBV Technologies S.A. and Citizens JMP Securities, LLC
5.1    Opinion of Gide Loyrette Nouel A.A.R.P.I.
23.1    Consent of Gide Loyrette Nouel A.A.R.P.I. (included in Exhibit 5.1)
99.1    Press Release of DBV Technologies S.A. dated September 5, 2025, furnished herewith
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

    DBV Technologies S.A.
Date: September 5, 2025     By:  

/s/ Virginie Boucinha

    Name:   Virginie Boucinha
    Title:   Chief Financial Officer

FAQ

What did DBV Technologies (DBVT) announce in the 8-K dated September 5, 2025?

The 8-K states a S-3 registration No. 333-271166, a Sales Agreement with Citizens JMP Securities executed on September 5, 2025, a counsel opinion and consent from Gide Loyrette Nouel, and a furnished press release.

Does the filing say how much capital DBVT will raise under the S-3?

No. The filing does not disclose any offering size, pricing, or timetable for potential share sales.

Who is the placement agent named in the filing?

The sales agreement is with Citizens JMP Securities, LLC.

Was there a press release related to this 8-K?

Yes. A press release dated September 5, 2025 is furnished with the filing.

Who signed the 8-K for DBVT?

The filing is signed by Virginie Boucinha, Chief Financial Officer.
Dbv Technologies S A

NASDAQ:DBVT

DBVT Rankings

DBVT Latest News

DBVT Latest SEC Filings

DBVT Stock Data

437.14M
29.70M
5.3%
0.07%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
France
CHATILLON